Globus Medical Shares Surge on Exceptional Quarterly Performance
Published on 11/11/2025 at 10:10 | Redaktion boerse-global.de
The medical technology sector is witnessing a remarkable performance from Globus Medical, whose recent quarterly results have generated significant market enthusiasm. The company’s latest financial disclosures have not only surpassed expectations but have also triggered substantial revisions in analyst assessments.
During the third quarter of 2025, Globus Medical delivered financial results that dramatically outpaced market forecasts. Revenue climbed 22.9% to reach $769 million, with the recently integrated Nevro business contributing significantly to this expansion. Even more impressive was the adjusted earnings performance, with per-share profits surging 42.6% to $1.18, substantially above the $0.79 consensus estimate among market analysts.
Management has responded to this strong performance by raising full-year guidance. The company now anticipates 2025 revenue between Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
